Free Redacted Document - District Court of Delaware - Delaware

Case 1 :04-cv—00171-GIVIS Document 115 Filed 07/10/2006 Page 1 of 2
CONNOLLY BOVE LODGE & HUTZ LLP
The Nemours Buiiding
l00? North Orange Street
P.O. Box 2207
Wilmington, DE 198992207
(302) 888-63%
Francis l)iGiovan11i (#3189)
MORGAN, LEWIS & BOCKIUS LLP
l0} Park Avenue
New York, New York 10178
(212) 309-6000
Brian P. Murphy, Esq. pro imc vice
{N THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE
·-·-· -—---—- -—-·--···—·· ————-—- -·--—·-·—··~···-~·-····-—-···~-·-———»···-··-·---··—•·--— —--·——- -—·-——X_
GLAXO GROUP LIMITED :
PI . {ff. REDACTEI) VERSION
im ‘ = j 0.1. # 98
v. · :
TEVA PHARMACEUTECALS USA, INC. and Civil Action No. 04—}7i—l TEVA PHARi\/lACEL?TICAL INDUSTRIES 2 _
LIMITED :
Defendants. ;
..........................................»..............rr.... Qi
DECLARATION O}? BRADLEY B. AMNDI-BRSON, PHJ).,
IN SUPPORT OF PLAINTIFF GLAXO GROUP LIMI'i`ED’S OPENING
CLAIM CONSTRUCTION BRIEF ON U.S. PATENT NO. 5..063,249
I, Bradley D. Anderson, Phi)., declare as follows:
1. I have been retained by Morgan, Lewis & Bockius LLP to testify on behalf of
Plaintiff, Glaxo Group Limited ("Glaxo"}, as an expert in the fild of organic chemistry. drug
product stabiiity, and stability testing.
2. My qualifications as an expert in this lield are established in my curricu/zmz vitae,
1

Case 1 :04-cv-00171-GIVIS Document 115 Filed 07/10/2006 Page 2 of 2
attached as Exhibit l to my affirmative expert report entitled “‘Bradiey D. Anderson, Ph.D., Fed.
R. Civ. P. 26(a)(2) Expert Witness Report Concerning The Issue of lnheingement of Glaxo’s ‘249
Patent? My aftirmative report and corresponding exhibits are attached hereto as Exhibit A.
3. My rebuttal expert report entitled "Bradley B. Anderson, Ph.D._, Fed. R. Civ. P.
26(a){2) Rebuttal Expert Witness QReport" and corresponding exhibits are attached hereto as
Exhibit B.
4. My first supplemental expert report entitled "Bradley D. Anderson, Ph.D., Fed. R.
Civ. 9. 26(a)(2) Supplemental Expert Witness Report Responsive to Prof K.i`obe’s Beposition
Testimony” is attached hereto as Exhibit C.
5. My second supplemental expert report entitled “Bradley D. Anderson, ?h.i)., Fed.
R. Civ- P. 26(a)(2) Second Supplemental Expert Witness Report" is attached hereto as Exhibit i).
6. I offer this declaration in support of Plaintiff Glaxo Group Limited’s {Jpening
Claim Construction Brief on U.S. Patent No. 5,068,249 to be tiled with the Court on J uae 30,
2006.
7. In my opinion, “OI'3l3£ZiH1iY1lS`{f£i{i0I1" is traditionally used by those of ordinary
skill in the art to indicate administration through the month and into the stomach for
gastrointestinal absorption.
8. The opinions and bases therefore, expressed herein and in my attached expert
reports, are those which { would ofter if called to testify at a hearing or at a trial in this matter.
I declare under penalty of perjury under the laws ofthe United States that the
foregoing is true and correct to th best of my knowledge and belief
Dated: June 2006 2
Bradley, D. Anderson, Ph.D.
2

Case 1:04-cv-00171-GMS

Document 115

Filed 07/10/2006

Page 1 of 2

Case 1:04-cv-00171-GMS

Document 115

Filed 07/10/2006

Page 2 of 2